ArticleFrontiers in health services2025
COVID-19 vaccine uptake at six months post vaccine availability in Central Texas: an observational study disentangling the moveable middle.
Article in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vaccine hesitancy is a multifactorial construct that posits vaccine uptake is based on person, place, time, and vaccine type. This study sought to identify individuals at about the six-month mark of COVID-19 vaccine availability in Central Texas to determine if they were vaccine acceptors, vaccine refusers, or in the moveable middle using the COVID-19 Vaccination Uptake Behavioral Science Task Force framework developed for the US Centers for Medicare and Medicaid Services and to disentangle individuals in the moveable middle to either vaccine acceptors or vaccine refusers. Methods: An online survey was distributed to individuals with Affordable Care Act insurance to assess: (1) COVID-19 vaccine uptake; and (2) plans to obtain a COVID-19 vaccine for those who had not yet received at least one dose of a COVID-19 vaccine. The study period was June 27, 2021, through July 13, 2021. Quantitative and qualitative data were collected. Results: 900 individuals participated in this study. The point prevalence of COVID-19 vaccine acceptance and refusal was 94.9% ( Conclusions: Real-world evidence at the time of a public health emergency can be used to determine point prevalence of vaccine uptake to stratify individuals as vaccine acceptors, vaccine refusers, or the moveable middle. Such evidence can be used to support health policy and planning during a public health emergency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.